These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 29661414)
1. Dexmedetomidine metabolic clearance is not affected by fat mass in obese patients. Rolle A; Paredes S; Cortínez LI; Anderson BJ; Quezada N; Solari S; Allende F; Torres J; Cabrera D; Contreras V; Carmona J; Ramírez C; Oliveros AM; Ibacache M Br J Anaesth; 2018 May; 120(5):969-977. PubMed ID: 29661414 [TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine pharmacokinetics in the obese. Cortínez LI; Anderson BJ; Holford NH; Puga V; de la Fuente N; Auad H; Solari S; Allende FA; Ibacache M Eur J Clin Pharmacol; 2015 Dec; 71(12):1501-8. PubMed ID: 26407689 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of dexmedetomidine administered to patients with end-stage renal failure and secondary hyperparathyroidism undergoing general anaesthesia. Zhong W; Zhang Y; Zhang MZ; Huang XH; Li Y; Li R; Liu QW J Clin Pharm Ther; 2018 Jun; 43(3):414-421. PubMed ID: 29247451 [TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery. Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862 [TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of dexmedetomidine in infants after open heart surgery. Su F; Nicolson SC; Gastonguay MR; Barrett JS; Adamson PC; Kang DS; Godinez RI; Zuppa AF Anesth Analg; 2010 May; 110(5):1383-92. PubMed ID: 20418300 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamics of intravenous dexmedetomidine in morbidly obese patients undergoing laparoscopic surgery. Xu B; Zhou D; Ren L; Shulman S; Zhang X; Xiong M J Anesth; 2017 Dec; 31(6):813-820. PubMed ID: 28828532 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of dexmedetomidine during analgosedation in ICU patients. Smuszkiewicz P; Wiczling P; Ber J; Warzybok J; Małkiewicz T; Matysiak J; Klupczyńska A; Trojanowska I; Kokot Z; Grześkowiak E; Krzyzanski W; Bienert A J Pharmacokinet Pharmacodyn; 2018 Apr; 45(2):277-284. PubMed ID: 29290034 [TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics of Dexmedetomidine After Short Intravenous Infusion in Chinese Children. Liu HC; Lian QQ; Wu FF; Wang CY; Sun W; Zheng LD; Schüttler J; Ihmsen H Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):201-211. PubMed ID: 27037817 [TBL] [Abstract][Full Text] [Related]
9. Population Pharmacokinetic Model of Dexmedetomidine in a Heterogeneous Group of Patients. Ber J; Wiczling P; Hołysz M; Klupczyńska A; Bartkowska-Śniatkowska A; Bieda K; Smuszkiewicz P; Nowicka M; Żurański Ł; Sobczyński P; Matysiak J; Grześkowiak E; Bienert A J Clin Pharmacol; 2020 Nov; 60(11):1461-1473. PubMed ID: 32500578 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of Dexmedetomidine in Infants and Children After Orthotopic Liver Transplantation. Damian MA; Hammer GB; Elkomy MH; Frymoyer A; Drover DR; Su F Anesth Analg; 2020 Jan; 130(1):209-216. PubMed ID: 30198929 [TBL] [Abstract][Full Text] [Related]
11. Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers. Dyck JB; Maze M; Haack C; Azarnoff DL; Vuorilehto L; Shafer SL Anesthesiology; 1993 May; 78(5):821-8. PubMed ID: 8098191 [TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine pharmacokinetics in pediatric intensive care--a pooled analysis. Potts AL; Anderson BJ; Warman GR; Lerman J; Diaz SM; Vilo S Paediatr Anaesth; 2009 Nov; 19(11):1119-29. PubMed ID: 19708909 [TBL] [Abstract][Full Text] [Related]
14. Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Cortínez LI; Anderson BJ; Penna A; Olivares L; Muñoz HR; Holford NH; Struys MM; Sepulveda P Br J Anaesth; 2010 Oct; 105(4):448-56. PubMed ID: 20710020 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic study of dexmedetomidine in elderly patients during spinal anesthesia. Kuang Y; Zhang RR; Pei Q; Tan HY; Guo CX; Huang J; Xiang YX; Ouyang W; Duan KM; Wang SY; Yang GP Int J Clin Pharmacol Ther; 2015 Dec; 53(12):1005-14. PubMed ID: 26413731 [TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of dexmedetomidine in patients with obstructive jaundice: A clinical trial. Song JC; Gao H; Qiu HB; Chen QB; Cai MH; Zhang MZ; Lu ZJ PLoS One; 2018; 13(11):e0207427. PubMed ID: 30427948 [TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetics of Dexmedetomidine in Infants. Greenberg RG; Wu H; Laughon M; Capparelli E; Rowe S; Zimmerman KO; Smith PB; Cohen-Wolkowiez M J Clin Pharmacol; 2017 Sep; 57(9):1174-1182. PubMed ID: 28444697 [TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine disposition in children: a population analysis. Potts AL; Warman GR; Anderson BJ Paediatr Anaesth; 2008 Aug; 18(8):722-30. PubMed ID: 18613931 [TBL] [Abstract][Full Text] [Related]
19. Does intranasal dexmedetomidine provide adequate plasma concentrations for sedation in children: a pharmacokinetic study. Miller JW; Balyan R; Dong M; Mahmoud M; Lam JE; Pratap JN; Paquin JR; Li BL; Spaeth JP; Vinks A; Loepke AW Br J Anaesth; 2018 May; 120(5):1056-1065. PubMed ID: 29661383 [TBL] [Abstract][Full Text] [Related]
20. Propofol clearance in morbidly obese children and adolescents: influence of age and body size. Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA Clin Pharmacokinet; 2012 Aug; 51(8):543-51. PubMed ID: 22690673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]